Management of fungal infections in the intensive care unit: A survey of UK practice

British Journal of Anaesthesia

Volumn 106, Issue 6, 2011, Pages 827-831

  Chalmers, C M ^a,b   Bal, A M ^a  

^a CROSSHOUSE HOSPITAL   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

candidiasis; candidiasis invasive; data collection; health care surveys; intensive care

Indexed keywords

AMPHOTERICIN; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDEMIA; CENTRAL VENOUS CATHETER; HEALTH CARE SURVEY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MYCOSIS; NONHUMAN; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 79957494905     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer089     Document Type: Article

References (24)

1. Rodriguez-Créixems M, Alcalá L, Muñoz P, et al. Bloodstream infections: evolution and trends in the microbiology workload, incidence and etiology, 1985-2006. Medicine 2008; 87: 234-49
2. Marchetti O, Bille J, Fluckiger U, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004; 38: 311-20 (Pubitemid 38200105)
3. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17 (Pubitemid 39050477)
4. Aliyu SH, Enoch DA, Abubakar II, et al. Candidaemia in a large teaching hospital: a clinical audit. Q J Med 2006; 99: 655-63 (Pubitemid 44542314)
5. Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003; 3: 230-40 (Pubitemid 36389186)
6. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35
7. Odds FC, Hanson MF, Davidson AD, et al. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 2007; 56: 1066-75 (Pubitemid 47262669)
8. Kibbler CC, Seaton S, Barnes RA, et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54: 18-24 (Pubitemid 38002021)
9. Chalmers CM, Bal AM. Management of fungal infections in the intensive care unit-a survey of UK practice. Intensive Care Med 2010; 36: 251
10. Schuster MG, Edwards JE, Sobel JD, et al. Empirical fluconazole versus placebo for intensive care unit patients. A randomized trial. Ann Intern Med 2008; 149: 83-90 (Pubitemid 352008596)
11. Kauffman CA. Epidemiology and pathogenesis of candidemia inadults. In: Basow DS, ed. UpToDate. Waltham, MA: UpToDate, 2010
12. Zilberberg MD, Shorr AF. Fungal Infections in the ICU. Infect Dis Clin N Am 2009; 23: 625-42
13. Leon C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system ('Candida score') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34: 730-7
14. Ostrosky-Zeichner L, Sable C, Sobel J, et al. Multicenter retrospective development and validation of a clinical prediction rule for Nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007; 26: 271-6 (Pubitemid 46572022)
15. Méan M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 2008; 12: 204-12
16. Leroy O, Gangneux JP, Montravers P, et al. Epidemiology, management and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009; 37: 1612-8
17. Bassetti M, Righi E, Costa A, et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006; 6: 21-6
18. Playford EG, Marriot D, Nguyen Q, et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 2008; 36: 2034-9
19. Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773-80 (Pubitemid 34535196)
20. Garey KW, Turpin RS, Bearden DT, et al. Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study. Int J Antimicrob Agents 2007; 29: 557-62 (Pubitemid 46560362)
21. Parkins MD, Sabuda DM, Elsayed S, et al. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007; 60: 613-8 (Pubitemid 47299877)
22. Schelenz S, Barnes RA, Kibbler CC, et al. Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit. J Infect 2009; 58: 145-53
23. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidaemia? An evidence based review. Clin Infect Dis 2002; 34: 591-9 (Pubitemid 34165320)
24. Donahue SP, Greven CM, Zuravleff JJ, et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 1994; 101: 1302-9 (Pubitemid 24236091)